AstraZeneca LP et al v. InvaGen Pharmaceuticals Inc. > Summary
Court Case Number 1:17-cv-01073
Filing Date Aug 2, 2017
Termination Date Mar 9, 2018
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesRichard G. Andrews
Defendant
Plaintiff Attorneys
8ASTRAZENECA LP
Attorney Name: Michael P. Kelly
McCarter & English
ASTRAZENECA LP
Attorney Name: Benjamin A. Smyth
McCarter & English
AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Benjamin A. Smyth
McCarter & English
ASTRAZENECA LP
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
ASTRAZENECA LP
Attorney Name: Daniel M. Silver
McCarter & English
Defendant Attorneys
InvaGen Pharmaceuticals, Inc.
Attorney Name: R. Touhey Myer
Offit Kurman
Counter Defendant
6AstraZeneca
Attorney Name: Benjamin A. Smyth
McCarter & English
ASTRAZENECA LP
Attorney Name: Benjamin A. Smyth
McCarter & English
AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
ASTRAZENECA LP
Attorney Name: Michael P. Kelly
McCarter & English
ASTRAZENECA LP
Attorney Name: Daniel M. Silver
McCarter & English
Counter Claimant
InvaGen Pharmaceuticals, Inc.
Attorney Name: R. Touhey Myer
Offit Kurman
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| RE046276 | Triazolo(4,5-D)pyrimidine compounds | Jan 17, 2017 |
| 07265124 | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound | Sep 4, 2007 |
| 07250419 | Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition | Jul 31, 2007 |
| 06525060 | Triazolo(4,5-d)pyrimidine compounds | Feb 25, 2003 |
